Barclays lowered the firm’s price target on MetLife (MET) to $95 from $96 and keeps an Overweight rating on the shares following the Q4 report.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback